Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

Jean Claude Reubi, Jean-Claude Schär, Beatrice Waser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 1.1K citations

Medicine, Nuclear Medicine, Radiology +15

MIRDOSE: Personal Computer Software for Internal Dose Assessment in Nuclear Medicine

David Piwnica-Worms · 1996 · 503 citations

Medicine, Nuclear Engineering, Nuclear Medicine +16

Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy

A. Heppeler, Sylvie Froidevaux, Helmut R. Mäcke et al. · Chemistry - A European Journal · 1999 · 334 citations · Full text

Medicine, Medicinal Chemistry, Nuclear Medicine +17

[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation

Willem H. Bakker, Rainer Albert, Christian Bruns et al. · Life Sciences · 1991 · 327 citations

Medicine, Oncology, Radiology +16